Free IBD Clinical Decision Support Tool (CDST)

This cutting-edge, web-based tool empowers health care providers to predict patient responses to biologic or targeted therapies before treatment even begins. Take advantage of features, such as session history, a resource library, CME, risk assessment, and response prediction — all for free.
Top 15 high-impact basic research articles of 2024

A look back at the top-read basic research articles.
Announcing the AGA-Pfizer Beacon of Hope Awards for Gender and Health Equity

Submit your application or nominate a deserving colleague by March 17.
AGA is pushing for improved access to obesity medication
We’re continuing our advocacy efforts to fight obesity by urging CMS to expand anti-obesity medication coverage.
Best screening and vaccination practices for IBD patients
13 tips to help you screen for non-colorectal cancers and provide vaccine guidance.
New guideline recommends antiviral drugs for patients at risk of hepatitis B reactivation
Our latest clinical guideline focuses on preventing and managing hepatitis B virus reactivation (HBVr) in patients on immunosuppressive drugs.
AGA to help develop follow-up CRC quality measures
We’re partnering with CMSS, NCQA, and the CDC to develop healthcare quality measures around abnormal CRC screening results.
Apply today for a $1,000 educational grant from the Academy of Educators
Join the Academy of Educators and apply by Mar. 3.
Registration now open for DDW ® 2025 and the AGA-ASGE Postgraduate Course
Be an early bird! Discounted rates are available through Feb. 26, 2025.
Expert insights on nonampullary duodenal lesions
13 tips to help you care for patients with nonampullary duodenal polyps.